← FDA DRUG APPROVALS

FDA NDA · NDA017283

XENON XE 133

Sponsor: LANTHEUS MEDCL

APPLICATION
NDA017283
TYPE
NDA
ORIGINAL APPROVAL
1974-10-11
LATEST ACTION
1974-10-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

XENON XE 133Discontinued
XENON XE-133 6.3mCi/ML · INJECTABLE · INJECTION

Approval history

1974-10-11Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →